Topics

Allergan's Forest Labs Pays $750 Million to Settle Class Action Suit Over Alzheimer's Drug

20:00 EDT 27 Oct 2019 | BioSpace

The plaintiffs in the case alleged that Forest intentionally attempted to delay and impair generic competition of its immediate-release formulation of Namenda.

Original Article: Allergan's Forest Labs Pays $750 Million to Settle Class Action Suit Over Alzheimer's Drug

NEXT ARTICLE

More From BioPortfolio on "Allergan's Forest Labs Pays $750 Million to Settle Class Action Suit Over Alzheimer's Drug"

Quick Search

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...